jeudi 1 janvier 2015
Hair Loss:Study Results
Volunteers completedTocomin SupraBio ® ™ showed statistically
the most significant hair account post-supplementation (p <0.01). average
41.8% increase in the number of hairs
was observed after 8 months (Figure 1),
whereby
• 8 volunteers (40.0%) showed> 50%
hair growth
• voluntary 1 (5.0%) showed 25-50%
hair growth
• 9 volunteers (45.0%) showed
The hair growth of 10 to 25%
• voluntary 1 (5.0%) showed <10%
hair growth
SupraBio ™ supplemented group had a
slight decrease in the number of
bristles (5.0%).
2 shows one of the volunteers
before taking any Tocomin ® SupraBio ™
Figure 3 shows the same volunteer after
8 months Tocomin ® SupraBio ™
supplementation.In contrast, only 1 (12.5%) volunteer
placebo showed more
20% increase of the count hair while
3 volunteers (37.5%) showed negligible
increase. 4 (50.0%) volunteers had even
a decrease in the number of hairs. no
a statistically significant difference
(p> 0.05) in the number of hairs was
detected between baseline and post-complementation, thereby indicating that the
placebo effect did not occur during this
study and the increase of
hair observed in volunteers receiving
® ™ Tocomin SupraBio could be attributed
to tocotrienols supplementation.
In addition, statistically significant
difference (p <0.01) was detected in the
percentage change in the number of
hair between tocotrienol completed
gr oup and the placebo group.
Given the proven effectiveness
® ™ Tocomin SupraBio in promoting hair
g rowth in men and women with
androgenetic alopecia, the States
Patent Office and Trademark
g ranted a patent for Tocomin ® ™ SupraBio as hair growth
formulation (12).
Articles
0 comments:
Enregistrer un commentaire